TUBE1
gene geneOn this page
Also known as dJ142L7.2FLJ22589TUBE
Summary
TUBE1 (tubulin epsilon 1, HGNC:20775) is a protein-coding gene on chromosome 6q21, encoding Tubulin epsilon chain (Q9UJT0). It is a selective cancer dependency (DepMap: 56.5% of cell lines).
This gene encodes a member of the tubulin superfamily. This protein localizes to the centriolar sub-distal appendages that are associated with the older of the two centrioles after centrosome duplication. This protein plays a central role in organization of the microtubules during centriole duplication. A pseudogene of this gene is found on chromosome 5.
Source: NCBI Gene 51175 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 66 total — 1 pathogenic
- Cancer dependency (DepMap): dependent in 56.5% of screened cell lines
- MANE Select transcript:
NM_016262
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20775 |
| Approved symbol | TUBE1 |
| Name | tubulin epsilon 1 |
| Location | 6q21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ142L7.2, FLJ22589, TUBE |
| Ensembl gene | ENSG00000074935 |
| Ensembl biotype | protein_coding |
| OMIM | 607345 |
| Entrez | 51175 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 5 retained_intron, 5 protein_coding, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined
ENST00000368657, ENST00000368662, ENST00000441191, ENST00000603621, ENST00000603651, ENST00000603722, ENST00000604689, ENST00000604743, ENST00000604814, ENST00000604967, ENST00000605457, ENST00000856770, ENST00000856771, ENST00000937354, ENST00000956039
RefSeq mRNA: 1 — MANE Select: NM_016262
NM_016262
CCDS: CCDS5100
Canonical transcript exons
ENST00000368662 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001447692 | 112087410 | 112087482 |
| ENSE00001956692 | 112070663 | 112071570 |
| ENSE00003523823 | 112072758 | 112072898 |
| ENSE00003537359 | 112084189 | 112084246 |
| ENSE00003549928 | 112086556 | 112086608 |
| ENSE00003562346 | 112075937 | 112076112 |
| ENSE00003606979 | 112074710 | 112074850 |
| ENSE00003646398 | 112071902 | 112072076 |
| ENSE00003657301 | 112079633 | 112079754 |
| ENSE00003679572 | 112076322 | 112076509 |
| ENSE00003679984 | 112087233 | 112087306 |
| ENSE00003683668 | 112081092 | 112081207 |
Expression profiles
Bgee: expression breadth ubiquitous, 254 present calls, max score 95.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.8164 / max 206.8422, expressed in 1796 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 75150 | 20.4204 | 1794 |
| 75151 | 0.3960 | 176 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 95.50 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.35 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.28 | gold quality |
| oocyte | CL:0000023 | 95.06 | gold quality |
| cerebellum | UBERON:0002037 | 94.58 | gold quality |
| secondary oocyte | CL:0000655 | 93.84 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 93.78 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.52 | gold quality |
| body of uterus | UBERON:0009853 | 93.32 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.75 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 91.96 | gold quality |
| right atrium auricular region | UBERON:0006631 | 91.70 | gold quality |
| cardiac atrium | UBERON:0002081 | 91.58 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 91.55 | gold quality |
| right ovary | UBERON:0002118 | 91.53 | gold quality |
| left ovary | UBERON:0002119 | 91.51 | gold quality |
| apex of heart | UBERON:0002098 | 91.44 | gold quality |
| liver | UBERON:0002107 | 91.27 | gold quality |
| endocervix | UBERON:0000458 | 90.89 | gold quality |
| heart left ventricle | UBERON:0002084 | 90.78 | gold quality |
| spinal cord | UBERON:0002240 | 90.66 | gold quality |
| body of pancreas | UBERON:0001150 | 90.58 | gold quality |
| adrenal tissue | UBERON:0018303 | 90.56 | gold quality |
| cardiac ventricle | UBERON:0002082 | 90.52 | gold quality |
| heart | UBERON:0000948 | 90.41 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 90.27 | gold quality |
| right uterine tube | UBERON:0001302 | 90.16 | gold quality |
| tibial nerve | UBERON:0001323 | 90.13 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.02 | gold quality |
| ovary | UBERON:0000992 | 89.91 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.40 |
| E-GEOD-111727 | no | 240.62 |
| E-GEOD-75367 | no | 184.22 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
49 targeting TUBE1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-10393-3P | 99.72 | 66.56 | 961 |
| HSA-MIR-6801-5P | 99.72 | 66.50 | 981 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 56.5% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 3)
- EB1 recognizes the nucleotide state of tubulin in the microtubule lattice (PMID:19851462)
- Here, the authors report that centrioles in delta-tubulin and epsilon-tubulin null mutant human cells lack triplet microtubules and fail to undergo centriole maturation. (PMID:28906251)
- Exome sequencing of child-parent trios with bladder exstrophy: Findings in 26 children. (PMID:34355505)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tube1 | ENSDARG00000096620 |
| mus_musculus | Tube1 | ENSMUSG00000019845 |
| rattus_norvegicus | Tube1 | ENSRNOG00000000598 |
Paralogs (23): TUBG2 (ENSG00000037042), TUBA3D (ENSG00000075886), TUBB1 (ENSG00000101162), TUBB4A (ENSG00000104833), TUBD1 (ENSG00000108423), TUBA1B (ENSG00000123416), TUBA4A (ENSG00000127824), TUBG1 (ENSG00000131462), TUBB2A (ENSG00000137267), TUBB2B (ENSG00000137285), TUBA3E (ENSG00000152086), TUBA1A (ENSG00000167552), TUBA1C (ENSG00000167553), TUBB8B (ENSG00000173213), TUBB6 (ENSG00000176014), TUBAL3 (ENSG00000178462), TUBA8 (ENSG00000183785), TUBB4B (ENSG00000188229), TUBB (ENSG00000196230), TUBA3C (ENSG00000198033), TUBA4B (ENSG00000243910), TUBB3 (ENSG00000258947), TUBB8 (ENSG00000261456)
Protein
Protein identifiers
Tubulin epsilon chain — Q9UJT0 (reviewed: Q9UJT0)
Alternative names: Epsilon-tubulin
All UniProt accessions (4): Q9UJT0, A0A0B4J2B9, S4R3K3, S4R424
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Found in a complex with TEDC1, TEDC2, TUBE1 and TUBD1.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome.
Similarity. Belongs to the tubulin family.
RefSeq proteins (1): NP_057346* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000217 | Tubulin | Family |
| IPR003008 | Tubulin_FtsZ_GTPase | Domain |
| IPR004057 | Epsilon_tubulin | Family |
| IPR008280 | Tub_FtsZ_C | Homologous_superfamily |
| IPR017975 | Tubulin_CS | Conserved_site |
| IPR018316 | Tubulin/FtsZ_2-layer-sand-dom | Domain |
| IPR023123 | Tubulin_C | Homologous_superfamily |
| IPR036525 | Tubulin/FtsZ_GTPase_sf | Homologous_superfamily |
Pfam: PF00091, PF03953
UniProt features (4 total): sequence conflict 2, chain 1, binding site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UJT0-F1 | 89.07 | 0.73 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 148–154
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 130 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GSE45365_NK_CELL_VS_CD11B_DC_UP, MODULE_453, GOCC_MICROTUBULE_ORGANIZING_CENTER, KOYAMA_SEMA3B_TARGETS_UP, GOCC_CENTROSOME, GOBP_MITOTIC_CELL_CYCLE, PEART_HDAC_PROLIFERATION_CLUSTER_DN, RFX1_02, ZHENG_BOUND_BY_FOXP3, MARSON_BOUND_BY_E2F4_UNSTIMULATED, ZHENG_FOXP3_TARGETS_IN_THYMUS_DN, GARY_CD5_TARGETS_UP, GOCC_PERICENTRIOLAR_MATERIAL
GO Biological Process (4): microtubule cytoskeleton organization (GO:0000226), mitotic cell cycle (GO:0000278), centrosome cycle (GO:0007098), microtubule-based process (GO:0007017)
GO Molecular Function (3): structural constituent of cytoskeleton (GO:0005200), GTP binding (GO:0005525), nucleotide binding (GO:0000166)
GO Cellular Component (6): pericentriolar material (GO:0000242), cytoplasm (GO:0005737), microtubule (GO:0005874), centrosome (GO:0005813), cytoskeleton (GO:0005856), microtubule cytoskeleton (GO:0015630)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoskeleton organization | 2 |
| cytoskeleton | 2 |
| cellular anatomical structure | 2 |
| microtubule-based process | 1 |
| cell cycle | 1 |
| mitotic nuclear division | 1 |
| cell cycle process | 1 |
| microtubule organizing center organization | 1 |
| cellular process | 1 |
| structural molecule activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| centrosome | 1 |
| intracellular anatomical structure | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
3231 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TUBE1 | CNTRL | Q7Z7A1 | 819 |
| TUBE1 | NIN | Q8N4C6 | 788 |
| TUBE1 | CEP170 | Q5SW79 | 738 |
| TUBE1 | ODF2 | Q5BJF6 | 732 |
| TUBE1 | SASS6 | Q6UVJ0 | 701 |
| TUBE1 | CC2D2A | Q9P2K1 | 577 |
| TUBE1 | PLK4 | O00444 | 576 |
| TUBE1 | TUBD1 | Q9UJT1 | 576 |
| TUBE1 | CEP128 | Q6ZU80 | 564 |
| TUBE1 | NINL | Q9Y2I6 | 526 |
| TUBE1 | CEP192 | Q8TEP8 | 526 |
| TUBE1 | CPAP | Q9HC77 | 507 |
| TUBE1 | CEP135 | Q66GS9 | 501 |
| TUBE1 | STIL | Q15468 | 494 |
| TUBE1 | POC5 | Q8NA72 | 489 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TUBE1 | TEDC2 | psi-mi:“MI:0914”(association) | 0.530 |
| FGL1 | DNM1L | psi-mi:“MI:0914”(association) | 0.350 |
| DEF8 | DPYSL4 | psi-mi:“MI:0914”(association) | 0.350 |
| NPM1 | RPS3A | psi-mi:“MI:0914”(association) | 0.350 |
| P2RY10 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| GPR182 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| GPR45 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (32): TUBE1 (Affinity Capture-MS), TUBD1 (Affinity Capture-MS), C16orf59 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), C14orf80 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBD1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), C16orf59 (Affinity Capture-MS), C14orf80 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS)
ESM2 similar proteins: A1A4J7, A2CEI4, A2RV06, B2RYI0, E7F654, E7FAW3, E9QAM5, F1Q7Z7, F1QNV4, O01939, O75064, O75153, O95248, P97564, Q08CY4, Q0P4Q0, Q0VA04, Q1L908, Q1LXZ7, Q2YDW2, Q32PH0, Q3T1I9, Q3U1Y4, Q4JF28, Q5U249, Q61586, Q6GPP1, Q6PD24, Q6TEN6, Q6ZNJ1, Q6ZPE2, Q6ZPG2, Q6ZQA0, Q6ZTN6, Q764M6, Q7T006, Q7TMQ7, Q7ZVS8, Q80U56, Q861Y6
Diamond homologs: P04688, P18695, P23257, P23258, P23330, P25295, P32348, P34785, P34786, P34787, P38557, P38558, P42271, P49741, P53377, P54403, P54404, P54405, P83887, P83888, P86221, P90548, Q0VCD2, Q32KM1, Q39582, Q41807, Q41808, Q41874, Q4R7T7, Q55AR3, Q6DIM3, Q75A43, Q7Z9Z2, Q8HZV4, Q8SRD2, Q8VCK3, Q9GKK5, Q9NRH3, Q9R1K7, Q9UJT0
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| “vincaleukoblastine sulfate” | “down-regulates activity” | TUBE1 | “chemical inhibition” |
| TUBE1 | up-regulates | Microtubule_polimerization | |
| KATNAL2 | “down-regulates quantity by destabilization” | TUBE1 | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 155160 | GRCh38/hg38 6q16.3-22.31(chr6:100054889-120488154)x1 | Pathogenic |
SpliceAI
1749 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:112071900:A:AC | donor_gain | 1.0000 |
| 6:112071900:A:AT | donor_loss | 1.0000 |
| 6:112071900:AC:A | donor_gain | 1.0000 |
| 6:112071901:C:CC | donor_gain | 1.0000 |
| 6:112071901:CC:C | donor_gain | 1.0000 |
| 6:112071901:CCT:C | donor_gain | 1.0000 |
| 6:112072047:C:CT | acceptor_gain | 1.0000 |
| 6:112072047:C:T | acceptor_gain | 1.0000 |
| 6:112072072:TTAAT:T | acceptor_gain | 1.0000 |
| 6:112072073:TAAT:T | acceptor_gain | 1.0000 |
| 6:112072075:AT:A | acceptor_gain | 1.0000 |
| 6:112072076:TC:T | acceptor_loss | 1.0000 |
| 6:112072077:C:A | acceptor_loss | 1.0000 |
| 6:112072077:C:CC | acceptor_gain | 1.0000 |
| 6:112072078:T:G | acceptor_loss | 1.0000 |
| 6:112072796:T:A | donor_gain | 1.0000 |
| 6:112072894:CCAAT:C | acceptor_gain | 1.0000 |
| 6:112072895:CAAT:C | acceptor_gain | 1.0000 |
| 6:112072895:CAATC:C | acceptor_gain | 1.0000 |
| 6:112072897:ATCT:A | acceptor_loss | 1.0000 |
| 6:112072898:TCTG:T | acceptor_loss | 1.0000 |
| 6:112072899:C:CC | acceptor_gain | 1.0000 |
| 6:112072899:CT:C | acceptor_loss | 1.0000 |
| 6:112074851:C:CC | acceptor_gain | 1.0000 |
| 6:112075932:ATTAC:A | donor_loss | 1.0000 |
| 6:112075933:TTAC:T | donor_loss | 1.0000 |
| 6:112075934:TA:T | donor_loss | 1.0000 |
| 6:112075935:ACCTC:A | donor_loss | 1.0000 |
| 6:112075936:C:T | donor_loss | 1.0000 |
| 6:112076320:A:AC | donor_gain | 1.0000 |
AlphaMissense
3147 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:112087271:A:G | W21R | 0.999 |
| 6:112087271:A:T | W21R | 0.999 |
| 6:112076497:C:T | G154E | 0.998 |
| 6:112081093:A:G | W109R | 0.998 |
| 6:112081093:A:T | W109R | 0.998 |
| 6:112072033:A:G | W380R | 0.997 |
| 6:112072033:A:T | W380R | 0.997 |
| 6:112074850:G:C | S271R | 0.997 |
| 6:112074850:G:T | S271R | 0.997 |
| 6:112075938:T:G | S271R | 0.997 |
| 6:112081188:T:A | E77V | 0.997 |
| 6:112081207:C:G | A71P | 0.997 |
| 6:112087269:C:A | W21C | 0.997 |
| 6:112087269:C:G | W21C | 0.997 |
| 6:112087303:C:A | G10V | 0.997 |
| 6:112087303:C:T | G10D | 0.997 |
| 6:112072797:C:A | G352V | 0.996 |
| 6:112072800:C:A | R351I | 0.996 |
| 6:112074757:G:C | S302R | 0.996 |
| 6:112074757:G:T | S302R | 0.996 |
| 6:112074759:T:G | S302R | 0.996 |
| 6:112074834:C:G | G277R | 0.996 |
| 6:112074834:C:T | G277R | 0.996 |
| 6:112074841:T:A | R274S | 0.996 |
| 6:112074841:T:G | R274S | 0.996 |
| 6:112074842:C:G | R274T | 0.996 |
| 6:112076385:A:C | N191K | 0.996 |
| 6:112076385:A:T | N191K | 0.996 |
| 6:112076503:C:T | G152E | 0.996 |
| 6:112079746:C:T | G112D | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000085628 (6:112089430 T>G), RS1000431472 (6:112082923 G>A), RS1000802493 (6:112075710 T>C), RS1000919012 (6:112083320 A>C,T), RS1000968420 (6:112075214 G>A), RS1001653673 (6:112078549 T>C,G), RS1001874389 (6:112077213 C>T), RS1001883373 (6:112084457 A>G), RS1001936459 (6:112078887 C>T), RS1002140771 (6:112070181 C>G,T), RS1002334645 (6:112084137 T>C,G), RS1002390813 (6:112076850 G>A,T), RS1002540482 (6:112080536 T>C), RS1002808664 (6:112073321 T>A), RS1003119907 (6:112086937 T>C,G)
Disease associations
OMIM: gene MIM:607345 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
45 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 4 |
| Aflatoxin B1 | affects expression, decreases expression, decreases methylation | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Air Pollutants | increases abundance, increases expression, decreases expression | 2 |
| Benzo(a)pyrene | decreases expression | 2 |
| Hydrogen Peroxide | affects expression, decreases expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | affects binding, increases activity, increases expression | 1 |
| bisphenol A | affects expression | 1 |
| methylparaben | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| K 7174 | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| prothioconazole | increases expression | 1 |
| NSC668394 | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Gemcitabine | increases expression | 1 |
| Ampicillin | decreases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.